A carregar...
Publicação
Plasmatic Klotho and FGF23 levels as biomarkers of CKD-associated cardiac disease in type 2 diabetic patients
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 671.51 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Research over the past decade has focused on the role of Klotho as a cardio protective agent that prevents the effects of aging on the heart and reduces the burden of cardiovascular disease CVD. The role of the interaction between fibroblast growth factor 23-(FGF-23)/Klotho in Klotho-mediated actions is still under debate. The main objective was to ascertain the potential use of plasmatic Klotho and FGF23 as markers for CKD-associated cardiac disease and mortality.
Descrição
Palavras-chave
Klotho FGF-23 CKD CVD LVMI
Contexto Educativo
Citação
Editora
MDPI